AER vs FTAI

AER's Advanced Deterministic Scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. The stock trades at a significant discount to its growth-based intrinsic value of $621.86, yet well above the conservative Graham Number of $227.61, suggesting high growth expectations are priced in. Exceptional profitability metrics—such as a 61.58% operating margin and 21.71% ROE—contrast with a high debt/equity ratio of 2.43 and weak technical trend. Strong earnings growth and consistent analyst estimate beats support upside potential, but leverage and deteriorating technicals cap bullishness.

FTAI exhibits a stark dichotomy between explosive growth and precarious financial health, highlighted by a weak Piotroski F-Score of 2/9. While the company delivers impressive revenue growth (32.7%) and massive historical returns, it is burdened by extreme leverage with a Debt/Equity ratio of 10.46. The current price of $255.18 trades at a significant premium to both its Graham Number ($18.36) and Intrinsic Value ($135.7), suggesting the market is pricing in aggressive future expansion. Despite a 'strong_buy' analyst consensus, the combination of poor deterministic health scores and astronomical valuation metrics warrants a neutral stance.